Oxford University Press, The Oncologist, 6(25), p. 468-469, 2020
DOI: 10.1634/theoncologist.2019-0942
Full text: Unavailable
This commentary focuses on the promise of more effective and less toxic treatments for children with cancer in the age of targeted therapy, as well as the challenges still to be overcome to best inform pediatric drug development.